Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens
Authors
Keywords
DC-SIGN, Langerin, Human dendritic cells, Anti-tumor vaccination, Liposomes, Glycans
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 203, Issue -, Pages 67-76
Publisher
Elsevier BV
Online
2015-02-03
DOI
10.1016/j.jconrel.2015.01.040

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.